AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$630M |
| 2 |
Visa
V
|
+$363M |
| 3 |
MSCI
MSCI
|
+$322M |
| 4 |
Walt Disney
DIS
|
+$297M |
| 5 |
Monster Beverage
MNST
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$584M |
| 2 |
Nike
NKE
|
+$573M |
| 3 |
Meta Platforms (Facebook)
META
|
+$489M |
| 4 |
Adobe
ADBE
|
+$418M |
| 5 |
Advanced Micro Devices
AMD
|
+$416M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.76% |
| 2 | Healthcare | 17.68% |
| 3 | Financials | 13.09% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Archrock
AROC
$6.27B
| $1.1M | ﹤0.01% |
171,235
-15,160
| -8% | -$116K |
|
2227
Compass Diversified
CODI
$758M
| $1.1M | ﹤0.01% |
60,800
| – | – |
|
2228
Veeco
VECO
$3.05B
| $1.1M | ﹤0.01% |
59,900
+1,313
| +2% | +$26.9K |
|
2229
Lyell Immunopharma
LYEL
$317M
| $1.1M | ﹤0.01% |
7,473
| – | – |
|
2230
Allison Transmission
ALSN
$9.5B
| $1.09M | ﹤0.01% |
32,277
-5,842
| -15% | -$218K |
|
2231
Customers Bancorp
CUBI
$2.66B
| $1.09M | ﹤0.01% |
36,979
+63
| +0.2% | +$2.23K |
|
|
KAMN
2232
DELISTED
Kaman Corp
KAMN
| $1.09M | ﹤0.01% |
38,991
+14
| +0% | +$437 |
|
|
FBRT
2233
Franklin BSP Realty Trust
FBRT
$630M
| $1.09M | ﹤0.01% |
100,898
+2,199
| +2% | +$30.2K |
|
2234
LeMaitre Vascular
LMAT
$2.32B
| $1.09M | ﹤0.01% |
21,443
+27
| +0.1% | +$1.35K |
|
2235
Atlanta Braves Holdings Series B
BATRK
$3.26B
| $1.09M | ﹤0.01% |
39,478
+900
| +2% | +$24.5K |
|
2236
Caleres
CAL
$431M
| $1.09M | ﹤0.01% |
44,852
-132
| -0.3% | -$3.49K |
|
|
SLCA
2237
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $1.09M | ﹤0.01% |
99,134
+109
| +0.1% | +$1.39K |
|
2238
Madrigal Pharmaceuticals
MDGL
$10.8B
| $1.08M | ﹤0.01% |
16,700
| – | – |
|
2239
Vaxcyte
PCVX
$7.81B
| $1.08M | ﹤0.01% |
45,200
| – | – |
|
|
DMC
2240
Del Monte Corp
DMC
$1.41B
| $1.08M | ﹤0.01% |
46,641
-1,677
| -3% | -$46.7K |
|
2241
CryoPort
CYRX
$761M
| $1.08M | ﹤0.01% |
44,400
| – | – |
|
2242
Blink Charging
BLNK
$74.3M
| $1.08M | ﹤0.01% |
60,927
-7,396
| -11% | -$152K |
|
2243
Nurix Therapeutics
NRIX
$2.41B
| $1.08M | ﹤0.01% |
82,900
+9,639
| +13% | +$153K |
|
2244
Preferred Bank
PFBC
$1.24B
| $1.08M | ﹤0.01% |
16,539
+19
| +0.1% | +$1.33K |
|
|
MFA
2245
MFA Financial
MFA
$926M
| $1.08M | ﹤0.01% |
138,354
| – | – |
|
2246
Surgery Partners
SGRY
$2.01B
| $1.08M | ﹤0.01% |
45,998
+1,300
| +3% | +$41.5K |
|
2247
CareDx
CDNA
$2.26B
| $1.07M | ﹤0.01% |
63,100
-42
| -0.1% | -$901 |
|
2248
Joby Aviation
JOBY
$7.03B
| $1.07M | ﹤0.01% |
247,300
| – | – |
|
2249
AllianceBernstein
AB
$3.43B
| $1.07M | ﹤0.01% |
30,510
-500
| -2% | -$21.1K |
|
2250
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$1.01B
| $1.07M | ﹤0.01% |
38,567
| – | – |
|
Similar funds
AllianceBernstein's Q3 2022 Portfolio in Review
As of Q3 2022, AllianceBernstein held 3,359 positions worth $207B, down 5.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
AllianceBernstein's Q3 2022 filing shows 102 new, 1,361 increased, 1,417 reduced and 89 closed positions. Its largest new stake was Genmab: 5,779,489 shares worth $186M. The largest sale was Qualcomm, an estimated $584M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q3 2022 buy was Genmab: 5,779,489 shares worth $186M.
- AllianceBernstein added most to iShares Russell 1000 Growth ETF in Q3 2022, an estimated $630M increase.
- AllianceBernstein's biggest Q3 2022 reduction was Qualcomm, cutting an estimated $584M.
- AllianceBernstein fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $244M.
- AllianceBernstein's ten largest holdings make up 23% of its $207B portfolio in Q3 2022.
- AllianceBernstein opened 102 new positions and closed 89 in Q3 2022.
- AllianceBernstein's portfolio value fell 5.7% quarter-over-quarter to $207B.
Based on AllianceBernstein's 13F filing for Q3 2022, filed 15 Nov 2022.